Your browser doesn't support javascript.
loading
Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review.
Mushtaq, Adeela; Kapoor, Vikas; Latif, Azka; Iftikhar, Ahmad; Zahid, Umar; McBride, Ali; Abraham, Ivo; Riaz, Irbaz Bin; Anwer, Faiz.
Afiliación
  • Mushtaq A; Department of Medicine, Hematology and Oncology, University of Arizona, Tucson, AZ, United States.
  • Kapoor V; Department of Medicine, Hematology and Oncology, University of Arizona, Tucson, AZ, United States.
  • Latif A; Department of Medicine, Hematology and Oncology, University of Arizona, Tucson, AZ, United States.
  • Iftikhar A; Department of Medicine, Hematology and Oncology, University of Arizona, Tucson, AZ, United States.
  • Zahid U; Department of Medicine, Hematology and Oncology, University of Arizona, Tucson, AZ, United States; College of Public Health, University of Arizona, Tucson, AZ, United States.
  • McBride A; College of Pharmacy, Arizona Cancer center, University of Arizona, Tucson, AZ, 85721, United States.
  • Abraham I; Center for Health Outcomes & Pharmaco-Economic Research, UA College of Pharmacy, United States.
  • Riaz IB; Mayo Clinic, Department of Hematology and Oncology, Rochester, MN, United States.
  • Anwer F; Department of Medicine, Hematology and Oncology, University of Arizona, Tucson, AZ, United States. Electronic address: anwerf@email.arizona.edu.
Crit Rev Oncol Hematol ; 125: 1-11, 2018 May.
Article en En | MEDLINE | ID: mdl-29650268

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos